deltatrials
Completed PHASE1/PHASE2 NCT00425009

Therapeutic Effects of Berberine in Patients With Type 2 Diabetes

Effects of Berberine on Improvement of Glucose and Lipid Metabolism in Patients With Type 2 Diabetes

Sponsor: National Institutes of Health (NIH)

Conditions Type 2 Diabetes
Interventions Berberine Metformin
Updated 4 times since 2017 Last updated: Jan 18, 2007 Started: Jan 31, 2004 Completion: Dec 31, 2004

Listed as NCT00425009, this PHASE1/PHASE2 trial focuses on Type 2 Diabetes and remains completed. Sponsored by National Institutes of Health (NIH), it has been updated 4 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  4. Jan 2017 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

    First recorded

Jan 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institutes of Health (NIH)
  • Shanghai Jiao Tong University School of Medicine
Data source: Shanghai Jiao Tong University School of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Shanghai, China